FindTrial
Sign In

histamine dihydrochloride

DRUG5 trials

Sponsors

Probelte Pharma S.L., Maxim Pharmaceuticals, The Christie NHS Foundation Trust, Aalborg University

Conditions

DPT and DF.IgE-mediated respiratory allergic disease due to the allergen whose extract is to be standardizedItchingKidney CancerLeukemiaMelanoma (Skin)Metastatic Cancer

Phase 2

Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Metastatic Kidney Cancer
NCT00005038
The Christie NHS Foundation TrustKidney Cancer
Start: 1999-06-30Updated: 2013-09-20
“In vivo” biological standardization of the allergenic extracts Dermatophagoides pteronyssinus (DPT) and Dermatophagoides farinae (DF) in patients sensitized to them.
Not yet recruitingCTIS2026-525628-13-00
Probelte Pharma S.L.DPT and DF., IgE-mediated respiratory allergic disease due to the allergen whose extract is to be standardized
Target: 30Updated: 2026-06-26

Phase 3

Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Stage IV Melanoma Metastatic to the Liver
NCT00039234
Maxim PharmaceuticalsMelanoma (Skin), Metastatic Cancer
Start: 2002-09-30Updated: 2013-12-18
Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia
CompletedNCT00003991
Maxim PharmaceuticalsLeukemia
Start: 1998-07-31End: 2011-08-31Target: 360Updated: 2013-11-06

Unknown Phase

Role of Interleukin-13 Pathways on Pain and Itch Sensitivity ( IL-13 )
Active, not recruitingNCT07017231
Aalborg UniversityItching
Start: 2025-05-15End: 2026-12-31Target: 26Updated: 2025-06-12

Related Papers

Assessment of the consistency and robustness of results from a multicenter trial of remission maintenance therapy for acute myeloid leukemia.
2011-03-237 citations